Skip to main content

Main menu

  • Home
  • Content
    • Latest
    • Ahead of print
    • Archive
  • Info for
    • Authors
    • Reviewers
    • Subscribers
    • Institutions
    • Advertisers
  • About Us
    • About Us
    • Editorial Office
    • Editorial Board
  • More
    • Alerts
    • Feedback
    • Folders
    • Help
  • Other Publications
    • Saudi Medical Journal

User menu

  • My alerts
  • Log in

Search

  • Advanced search
Neurosciences Journal
  • Other Publications
    • Saudi Medical Journal
  • My alerts
  • Log in
Neurosciences Journal

Advanced Search

  • Home
  • Content
    • Latest
    • Ahead of print
    • Archive
  • Info for
    • Authors
    • Reviewers
    • Subscribers
    • Institutions
    • Advertisers
  • About Us
    • About Us
    • Editorial Office
    • Editorial Board
  • More
    • Alerts
    • Feedback
    • Folders
    • Help
  • Follow psmmc on Twitter
  • Visit psmmc on Facebook
  • RSS
Research ArticleOriginal Articles
Open Access

Assessment of the stroke-specific quality-of-life scale in KFHU, Khobar

A prospective cross-sectional study

Sarah M. Alotaibi, Horia M. Alotaibi, Amira M. Alolyani, Fawziah A. Abu Dali, Alaa K. Alshammari, Amani A. Alhwiesh, Danya M. Gari, Inam Khuda M.Q Khuda and Christopher A. Vallabadoss
Neurosciences Journal April 2021, 26 (2) 171-178; DOI: https://doi.org/10.17712/nsj.2021.2.20200126
Sarah M. Alotaibi
From the College of Medicine (Alotaibi S, Alotaibi H, Alolyani, Abudalli, Alshammari, Alhwiesh), from the Department of Family Medicine (Gari); and from the Deanship for Quality and Development (Vallabadoss), Department of Neurology (Khuda), College of Medicine, Imam Abdulrahman bin Faisal University, Dammam, Kingdom of Saudi Arabia
MBBS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Horia M. Alotaibi
From the College of Medicine (Alotaibi S, Alotaibi H, Alolyani, Abudalli, Alshammari, Alhwiesh), from the Department of Family Medicine (Gari); and from the Deanship for Quality and Development (Vallabadoss), Department of Neurology (Khuda), College of Medicine, Imam Abdulrahman bin Faisal University, Dammam, Kingdom of Saudi Arabia
MBBS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amira M. Alolyani
From the College of Medicine (Alotaibi S, Alotaibi H, Alolyani, Abudalli, Alshammari, Alhwiesh), from the Department of Family Medicine (Gari); and from the Deanship for Quality and Development (Vallabadoss), Department of Neurology (Khuda), College of Medicine, Imam Abdulrahman bin Faisal University, Dammam, Kingdom of Saudi Arabia
MBBS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fawziah A. Abu Dali
From the College of Medicine (Alotaibi S, Alotaibi H, Alolyani, Abudalli, Alshammari, Alhwiesh), from the Department of Family Medicine (Gari); and from the Deanship for Quality and Development (Vallabadoss), Department of Neurology (Khuda), College of Medicine, Imam Abdulrahman bin Faisal University, Dammam, Kingdom of Saudi Arabia
MBBS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alaa K. Alshammari
From the College of Medicine (Alotaibi S, Alotaibi H, Alolyani, Abudalli, Alshammari, Alhwiesh), from the Department of Family Medicine (Gari); and from the Deanship for Quality and Development (Vallabadoss), Department of Neurology (Khuda), College of Medicine, Imam Abdulrahman bin Faisal University, Dammam, Kingdom of Saudi Arabia
MBBS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amani A. Alhwiesh
From the College of Medicine (Alotaibi S, Alotaibi H, Alolyani, Abudalli, Alshammari, Alhwiesh), from the Department of Family Medicine (Gari); and from the Deanship for Quality and Development (Vallabadoss), Department of Neurology (Khuda), College of Medicine, Imam Abdulrahman bin Faisal University, Dammam, Kingdom of Saudi Arabia
MBBS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Danya M. Gari
From the College of Medicine (Alotaibi S, Alotaibi H, Alolyani, Abudalli, Alshammari, Alhwiesh), from the Department of Family Medicine (Gari); and from the Deanship for Quality and Development (Vallabadoss), Department of Neurology (Khuda), College of Medicine, Imam Abdulrahman bin Faisal University, Dammam, Kingdom of Saudi Arabia
MBBS, SBFM
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Inam Khuda M.Q Khuda
From the College of Medicine (Alotaibi S, Alotaibi H, Alolyani, Abudalli, Alshammari, Alhwiesh), from the Department of Family Medicine (Gari); and from the Deanship for Quality and Development (Vallabadoss), Department of Neurology (Khuda), College of Medicine, Imam Abdulrahman bin Faisal University, Dammam, Kingdom of Saudi Arabia
MBBS, FCPS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christopher A. Vallabadoss
From the College of Medicine (Alotaibi S, Alotaibi H, Alolyani, Abudalli, Alshammari, Alhwiesh), from the Department of Family Medicine (Gari); and from the Deanship for Quality and Development (Vallabadoss), Department of Neurology (Khuda), College of Medicine, Imam Abdulrahman bin Faisal University, Dammam, Kingdom of Saudi Arabia
MPhil, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • eLetters
  • Info & Metrics
  • References
  • PDF
Loading

Article Figures & Data

Tables

    • View popup
    Table 1

    - Demographic characteristics of the participants.

    CharacteristicsVariable
    Gender
     Male46 (57.5)
     Female34 (42.5)
    Average age, y (range)55.53 (26-90)
    Age
     <45 years21 (26.3)
     45-55 years19 (23.7)
     56-65 years20 (25.0)
     65 years20 (25.0)
    Stroke subtype
     Ischemic75 (93.8)
     haemorrhagic5 (6.2)
    Recurrence
     Not recurrent62 (77.5)
     Recurrent18 (22.5)
    Duration
     <1 year32 (40.0)
     1–2 years29 (36.3)
     3–5 years11 (13.8)
     >5 years8 (10.0)
    Comorbidities and risk factors
     Hypertension59 (73.8)
     Diabetes mellitus46 (58.7)
     Dyslipidemia32 (40.0)
     Obesity15 (18.8)
     Ischemic heart disease13 (16.0)
     Smoking12 (15 .0)
     Atrial fibrillation7 (8.75)
    Rankin scale
     0-2 points46 (57.5)
     3-5 points34 (42.5)
    • Values are presented as numbers and percentages (%).

    • View popup
    Table 2

    - Quality of life of the participants.

    Quality of lifeNMeanMedianMin.Max.SD
    Energy803.413.661.05.01.40
    Family roles803.744.001.05.01.34
    Language804.155.001.05.01.28
    Mobility803.373.661.05.01.43
    Mood804.074.701.05.01.53
    Personality803.734.001.05.01.36
    Self-care803.914.901.05.01.48
    Social role803.664.001.05.01.38
    Thinking803.844.331.05.01.39
    Upper extremity function804.015.001.05.01.48
    Vision803.754.001.05.01.37
    Work/productivity803.774.501.05.01.47
    SS-QOL803.724.020.984.901.02
    • N: number, Min: minimum, Max: maximum, SD: standard deviation,SS-QOL: stroke-specific quality-of-life

    • View popup
    Table 3

    - Quality of life of the participants according to age.

    Age<45 years old45-55 years old56-65 years old>65 years oldP-value
    MeanSDMeanSDMeanSDMeanSD
    Energy3.541.223.401.443.431.543.281.470.95
    Family roles4.061.293.541.523.881.223.451.340.43
    Language4.620.824.381.283.781.483.821.350.08
    Mobility4.04*0.993.32*1.443.56*1.422.55*1.480.007*
    Mood4.171.153.841.474.442.053.831.330.54
    Personality3.711.433.631.453.901.353.681.290.93
    Self-care4.58*0.813.98*1.623.90*1.523.17*1.580.02*
    Social roles4.061.133.641.673.481.233.451.450.46
    Thinking4.061.083.701.574.061.403.531.500.53
    Upper extremity function4.680.714.051.593.841.693.451.590.05
    Vision3.951.253.421.793.951.323.681.080.57
    Work/productivity4.60*0.783.35*1.773.90*1.363.20*1.480.008*
    SS-QOL4.130.563.651.253.761.053.321.020.08
    • SD: standard deviation, SS-QOL: stroke-specific quality of life, *p-value is significant at <0.05

    • View popup
    Table 4

    - Quality of life of the participants according to type of stroke.

    TypeNMeanSDP-value
    Energy
     Ischemic753.481.360.094
     Haemorrhagic52.401.67
    Family roles
     Ischemic753.771.310.356
     Haemorrhagic53.201.78
    Language
     Ischemic754.171.270.572
     Haemorrhagic53.841.49
    Mobility
     Ischemic753.431.410.191
     Haemorrhagic52.561.50
    Mood
     Ischemic754.171.490.029*
     Haemorrhagic52.641.47
    Personality
     Ischemic753.801.330.071
     Haemorrhagic52.661.49
    Self-care
     Ischemic753.981.440.137
     Haemorrhagic52.961.93
    Social Role
     Ischemic753.731.350.075
     Haemorrhagic52.601.51
    Thinking
     Ischemic753.801.410.305
     Haemorrhagic54.460.76
    Upper extremity function
     Ischemic754.071.460.185
     Haemorrhagic53.161.80
    Vision
     Ischemic753.721.400.462
     Haemorrhagic54.200.83
    Work/productivity
     Ischemic753.871.450.023*
     Haemorrhagic52.331.02
    SS-QOL
     Ischemic753.771.010.094
     Haemorrhagic52.980.87
    • SS-QOL - stroke specific quality of life scale, SD - standard deviation, *P-value is significant at <0.05

    • View popup
    Table 5

    - Quality of life of the participants according to the recurrence of stroke.

    Recurrence of strokeRecurrent (n=18)Non-recurrent (n=62)P-value
    MeanSDMeanSD
    Energy3.381.373.421.410.92
    Family roles3.481.053.811.410.28
    Language4.041.114.191.330.67
    Mobility3.471.353.351.450.75
    Mood3.32*1.374.29*1.510.01*
    Personality3.591.483.771.330.62
    Self-care3.581.584.011.450.28
    Social roles3.05*1.633.84*1.250.03*
    Thinking3.531.573.931.330.28
    Upper extremity function3.781.534.081.480.46
    Vision4.071.403.661.360.27
    Work/productivity3.631.583.821.450.62
    SS-QOL3.490.903.791.040.28
    • SS-QOL - stroke specific quality of life scale, SD - standard deviation,*P-value is significant at <0.05

    • View popup
    Table 6

    - Quality of life of the participants according to comorbidities and risk factors.

    ComorbiditiesHypertension 59 (73.8%)Diabetes mellitus 47 (58.8%)Dyslipidemia 32 (40%)Obesity 15 (18.8%)Ischemic disease heart 13 (16.0%)Smoking 12 (15.0%)Atrial fibrillation 7 (8.8%)
    Mean+SDPMean+SDPMean +SDPMean+SDPMean+SDPMean+SDPMean+SDP
    Energy3.23+1.460.053.44+1.370.863.49+1.530.702.91+1.560.123.38+1.330.923.50+1.610.822.57+1.710.09
    Family roles3.51+1.430.01*3.87+1.300.303.78+1.400.833.33+1.570.193.74+1.320.993.88+1.480.683.14+1.670.22
    Language3.99+1.410.064.20+1.240.724.08+1.440.663.97+1.320.544.15+1.220.994.50+0.660.323.54+1.910.18
    Mobility3.14+1.450.01*3.29+1.450.543.33+1.540.812.62+1.350.023.30+1.340.843.84+1.460.223.26+1.860.82
    Mood3.98+1.680.374.28+1.640.144.30+1.840.274.40+2.320.364.21+2.440.724.63+2.400.172.65+1.490.009*
    Personality3.58+1.440.113.86+1.370.303.84+1.530.553.26+1.370.143.30+1.460.224.08+1.360.332.71+1.490.03*
    Self-care3.68+1.600.01*3.91+1.470.963.75+1.560.413.69+1.630.513.83+1.340.814.40+1.230.223.28+1.830.24
    Social roles3.46+1.430.03*3.77+1.370.383.64+1.420.913.76+1.460.773.46+1.350.563.86+1.600.582.60+1.500.03*
    Thinking3.78+1.470.513.99+1.350.264.06+1.470.254.15+1.170.343.69+1.270.664.47+1.120.093.14+1.770.16
    Upper extremity function3.77+1.590.01*4.08+1.420.613.87+1.620.483.66+1.540.314.07+1.300.874.40+1.400.333.42+1.810.27
    Vision3.50+1.450.005*3.68+1.370.553.52+1.500.203.08+1.340.03*3.89+1.110.694.30+1.210.132.85+1.570.06*
    Work3.48+1.570.002*3.73+1.460.763.82+1.500.833.15+1.630.063.56+1.420.564.08+1.360.442.71+1.600.04*
    SS-QOL3.53+1.090.004*3.77+1.000.583.71+1.160.953.45+0.990.263.66+0.920.824.10+0.990.162.97+1.340.04*
    • P: p-value, SS-QOL: stroke specific quality of life scale, SD: standard deviation, *P-value is significant at <0.05

PreviousNext
Back to top

In this issue

Neurosciences Journal: 26 (2)
Neurosciences Journal
Vol. 26, Issue 2
1 Apr 2021
  • Table of Contents
  • Cover (PDF)
  • Index by author
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on Neurosciences Journal.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Assessment of the stroke-specific quality-of-life scale in KFHU, Khobar
(Your Name) has sent you a message from Neurosciences Journal
(Your Name) thought you would like to see the Neurosciences Journal web site.
Citation Tools
Assessment of the stroke-specific quality-of-life scale in KFHU, Khobar
Sarah M. Alotaibi, Horia M. Alotaibi, Amira M. Alolyani, Fawziah A. Abu Dali, Alaa K. Alshammari, Amani A. Alhwiesh, Danya M. Gari, Inam Khuda M.Q Khuda, Christopher A. Vallabadoss
Neurosciences Journal Apr 2021, 26 (2) 171-178; DOI: 10.17712/nsj.2021.2.20200126

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Assessment of the stroke-specific quality-of-life scale in KFHU, Khobar
Sarah M. Alotaibi, Horia M. Alotaibi, Amira M. Alolyani, Fawziah A. Abu Dali, Alaa K. Alshammari, Amani A. Alhwiesh, Danya M. Gari, Inam Khuda M.Q Khuda, Christopher A. Vallabadoss
Neurosciences Journal Apr 2021, 26 (2) 171-178; DOI: 10.17712/nsj.2021.2.20200126
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • Methods.
    • Results.
    • Discussion
    • Acknowledgment.
    • Footnotes
    • References
  • Figures & Data
  • eLetters
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • The prevalence of seizures in children with developmental delay
  • Efficacy of repetitive paravertebral block combined with medication in the treatment of zoster-related pain with different courses
Show more ORIGINAL ARTICLES

Similar Articles

Navigate

  • home

More Information

  • Help

Additional journals

  • All Topics

Other Services

  • About

© 2025 Neurosciences Journal Neurosciences is copyright under the Berne Convention and the International Copyright Convention. All rights reserved. Neurosciences is an Open Access journal and articles published are distributed under the terms of the Creative Commons Attribution-NonCommercial License (CC BY-NC). Readers may copy, distribute, and display the work for non-commercial purposes with the proper citation of the original work. Electronic ISSN 1658-3183. Print ISSN 1319-6138.

Powered by HighWire